Literature DB >> 18929677

Applications of genetic programming in cancer research.

William P Worzel1, Jianjun Yu, Arpit A Almal, Arul M Chinnaiyan.   

Abstract

The theory of Darwinian evolution is the fundamental keystones of modern biology. Late in the last century, computer scientists began adapting its principles, in particular natural selection, to complex computational challenges, leading to the emergence of evolutionary algorithms. The conceptual model of selective pressure and recombination in evolutionary algorithms allow scientists to efficiently search high dimensional space for solutions to complex problems. In the last decade, genetic programming has been developed and extensively applied for analysis of molecular data to classify cancer subtypes and characterize the mechanisms of cancer pathogenesis and development. This article reviews current successes using genetic programming and discusses its potential impact in cancer research and treatment in the near future.

Entities:  

Mesh:

Year:  2008        PMID: 18929677      PMCID: PMC3298968          DOI: 10.1016/j.biocel.2008.09.025

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

Review 1.  Integrated analysis of genetic, genomic and proteomic data.

Authors:  David M Reif; Bill C White; Jason H Moore
Journal:  Expert Rev Proteomics       Date:  2004-06       Impact factor: 3.940

2.  Genetic algorithm for large-scale maximum parsimony phylogenetic analysis of proteins.

Authors:  Tobias Hill; Andor Lundgren; Robert Fredriksson; Helgi B Schiöth
Journal:  Biochim Biophys Acta       Date:  2005-08-30

3.  Detecting high-order interactions of single nucleotide polymorphisms using genetic programming.

Authors:  Robin Nunkesser; Thorsten Bernholt; Holger Schwender; Katja Ickstadt; Ingo Wegener
Journal:  Bioinformatics       Date:  2007-11-15       Impact factor: 6.937

4.  An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

Authors:  Lance D Miller; Johanna Smeds; Joshy George; Vinsensius B Vega; Liza Vergara; Alexander Ploner; Yudi Pawitan; Per Hall; Sigrid Klaar; Edison T Liu; Jonas Bergh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

Review 5.  Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades.

Authors:  A K Hubbard; R Rothlein
Journal:  Free Radic Biol Med       Date:  2000-05-01       Impact factor: 7.376

6.  MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer.

Authors:  Lennard J Dekker; Willem Boogerd; Guenther Stockhammer; Johannes C Dalebout; Ivar Siccama; Pingpin Zheng; Johannes M Bonfrer; Jan J Verschuuren; Guido Jenster; Marcel M Verbeek; Theo M Luider; Peter A Sillevis Smitt
Journal:  Mol Cell Proteomics       Date:  2005-06-21       Impact factor: 5.911

Review 7.  A constrained-syntax genetic programming system for discovering classification rules: application to medical data sets.

Authors:  Celia C Bojarczuk; Heitor S Lopes; Alex A Freitas; Edson L Michalkiewicz
Journal:  Artif Intell Med       Date:  2004-01       Impact factor: 5.326

8.  Genetic programming for classification and feature selection: analysis of 1H nuclear magnetic resonance spectra from human brain tumour biopsies.

Authors:  H F Gray; R J Maxwell; I Martínez-Pérez; C Arús; S Cerdán
Journal:  NMR Biomed       Date:  1998 Jun-Aug       Impact factor: 4.044

9.  Feature selection and molecular classification of cancer using genetic programming.

Authors:  Jianjun Yu; Jindan Yu; Arpit A Almal; Saravana M Dhanasekaran; Debashis Ghosh; William P Worzel; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

10.  The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer.

Authors:  Anirban P Mitra; Arpit A Almal; Ben George; David W Fry; Peter F Lenehan; Vincenzo Pagliarulo; Richard J Cote; Ram H Datar; William P Worzel
Journal:  BMC Cancer       Date:  2006-06-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.